Form 4: Erasca Inc. Director Trades Stock Options

Director Julie Hambleton acquired 29,888 stock options in Erasca, Inc. on June 26, 2026, with an exercise price of $16.01.

Summary

• Director Julie Hambleton acquired 29,888 stock options in Erasca, Inc. on June 26, 2026.
• The options have an exercise price of $16.01 per share.
• These options are exercisable starting June 26, 2027, and expire on June 26, 2036.
• The options vest fully on June 26, 2027, contingent on Hambleton's continued service to Erasca, Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it represents a standard compensation practice for a director rather than a significant strategic development or financial performance indicator.

Positives

• Director's acquisition of stock options indicates confidence in the company's future prospects.
• The options provide a potential upside for the director if the stock price increases above the exercise price.

Negatives

• The acquisition is of options, not direct shares, meaning the immediate value is not realized.
• Vesting is contingent on continued employment, introducing a performance-based element for the director.

Risks

• The value of the options is subject to market fluctuations and the company's performance.
• If the stock price does not exceed $16.01 by the expiration date, the options may expire worthless.

Future Outlook

The future outlook for the options is dependent on the company's stock performance and the reporting person's continued service, with full vesting and exercisability expected by June 26, 2027.

Industry Context

StockSavvy.ai notes that the acquisition of stock options by a director is a common practice in the biotechnology and pharmaceutical sectors, like Erasca, Inc., as a means to align executive interests with shareholder value and incentivize long-term performance.

Stakeholder Impact

• Shareholders: The issuance of options dilutes existing share ownership, but also aligns director incentives with potential stock appreciation.
• Employees: This transaction is specific to the director and does not directly impact other employees, though it may reflect company-wide compensation strategies.
• Management: Reinforces the alignment of executive compensation with company performance and long-term value creation.

Next Steps

• Director Hambleton will continue her service to Erasca, Inc. until June 26, 2027, to ensure full vesting of the options.
• The options may be exercised between June 26, 2027, and June 26, 2036, depending on market conditions and the company's stock price.

Key Dates

Keywords

stock options, insider trading, Erasca Inc., ERAS, director compensation, equity awards, SEC Form 4